Search results
Results from the WOW.Com Content Network
UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium.UCB is an international company with revenue of €4.178 billion in 2016 [2] which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. [2]
Technical analysis is an analysis methodology for analysing and forecasting the direction of prices through the study of past market data, primarily price and volume. The efficacy of technical analysis is disputed by the efficient-market hypothesis , which states that stock market prices are essentially unpredictable, [ 5 ] and research on ...
Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details, and write-ups. Barbara Obstoj is the Managing Editor, which in 2009 acquired the archives of The Pharma Marketletter, a publication Barbara owned since 1991 and prior to that edited ...
Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence ...
On Tuesday, NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) revealed topline data from its Phase 3 BROADWAY clinical trial evaluating obicetrapib in adult patients with atherosclerotic ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This was above analysts' estimate of $2.42 billion, according to Refinitiv data. The beat was driven by strong uptake of its top-selling drug Trikafta, which recorded sales of $2.24 billion in the ...
Catalent, Inc. (Catalent Pharma Solutions), a subsidiary of Novo Holdings A/S since 2024, is a multinational corporation headquartered in Somerset, New Jersey. It is a provider of drug delivery technologies, drug development , drug manufacturing , biologics , gene therapy , and consumer health products.